Zydus Cadila and Lilly Enter US$300 M Research Pact |
Abstract
|
Taskin Ahmed |
|
Pfizer Looks for Growth in Generics and Eyecare |
Abstract
|
Taskin Ahmed |
|
Lilly Looks to NeuroSearch to Fill Pipeline Gap |
Abstract
|
Taskin Ahmed |
|
Merck Serono and Fast Forward to Speed Multiple Sclerosis Developments |
Abstract
|
Taskin Ahmed |
|
Merck to Merge with Schering-Plough in a US$41.1 B deal |
Abstract
|
Taskin Ahmed |
|
Roche Gets Genentech for US$46.8 B |
Abstract
|
Taskin Ahmed |
|
Could J&J Trip up the Merck and Schering-Plough Deal? |
Abstract
|
Taskin Ahmed |
|
Gilead Rescues CV Therapeutics |
Abstract
|
Taskin Ahmed |
|
Nycomed Looking for Buyers |
Abstract
|
Taskin Ahmed |
|
Is Allergan the Next Takeover Target? |
Abstract
|
Taskin Ahmed |
|
Elan’s Shares Rise on Takeover Speculation |
Abstract
|
Taskin Ahmed |
|
Biosimilars – a risky bet? |
Abstract
|
Taskin Ahmed |
|